15186 Federal Register / Vol. 62, No. 61 / Monday, March 31, 1997 / Notices

consumer complaint because it

contained personal information, but

would act to protect the information

from disclosure in litigation or

otherwise, then the Bureau Director

must obtain assurances that the

receiving agency will act to protect the

information as well.

The Bureau Directors’ authority under

this delegation may be redelegated.

Prior to disclosing consumer complaints

to foreign governments under the

foregoing delegation, the Bureau

Director shall, unless the disclosure is

needed to obtain information in a

pending Commission investigation,

transmit a proposed letter providing for

such disclosure to the Secretary and the

Secretary shall notify the Commission of

the proposed disclosure. If no

Commissioner objects to the proposed

disclosure within three days following

the Commission’s receipt of such

notification, the Secretary shall inform

the Bureau Director that he or she may

proceed with the disclosure.

Effective Date: March 14, 1997.

By direction of the Commission.

Donald S. Clark,

Secretary.

[FR Doc. 97–8063 Filed 3–28–97; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Antiterrorism and Effective Death

Penalty Act of 1996; Delegation of

Authority

Notice is hereby given that I have

delegated to the Director, Centers for

Disease Control and Prevention, with

authority to redelegate, all the

authorities vested in the Secretary of

Health and Human Services under

Section 511—Enhanced Penalties and

Biological Agents (42 U.S.C. 262), of the

Antiterrorism and Effective Death

Penalty Act of 1996 (Public Law 104–

132), as amended hereafter. This

delegation excludes the authority to

promulgate regulations and to submit

reports to the Congress.

This delegation became effective upon

date of signature. In addition, I have

affirmed and ratified any actions taken

by the Director, Centers for Disease

Control and Prevention or his

subordinates which, in effect, involved

the exercise of the authorities delegated

herein prior to the effective date of the

delegation.

Dated: March 18, 1997.

Donna E. Shalala,

Secretary.

[FR Doc. 97–7988 Filed 3–28–97; 8:45 am]

BILLING CODE 4160–18–M

Food and Drug Administration

Docket No. 97N–0117

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

opportunity for public comment on the

proposed collection of certain

information by the agency. Under the

Paperwork Reduction Act of 1995 (the

PRA), Federal agencies are required to

publish notice in the Federal Register

concerning each proposed collection of

information and to allow 60 days for

public comment in response to the

notice. This notice solicits comments on

the collection of information on a

medicated feed mill license application

form (form FDA 3448). FDA is also

announcing that this collection of

information has been submitted to the

Office of Management and Budget

(OMB) for emergency processing and

that OMB has approved the information

collection through June 30, 1997, under

OMB control number 0910–0337.

DATES: Submit written comments on the

collection of information by May 30,

1997.

ADDRESSES: Submit written comments

on the collection of information to the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

12420 Parklawn Dr., rm. 1–23,

Rockville, MD 20857. All comments

should be identified with the docket

number found in brackets in the

heading of this document.

FOR FURTHER INFORMATION CONTACT:

Denver Presley, Office of Information

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, rm. 16B–19, Rockville,

MD 20857, 301–827–1472.

SUPPLEMENTARY INFORMATION: Under the

PRA (44 U.S.C. 3501–3520), Federal

agencies must obtain approval from the

Office of Management and Budget

(OMB) for each collection of

information they conduct or sponsor.

‘‘Collection of information’’ is defined

in 44 U.S.C. 3502(3) and 5 CFR

1320.3(c) and includes agency requests

or requirements that members of the

public submit reports, keep records, or

provide information to a third party.

Section 3506(c)(2)(A) of the PRA (44

U.S.C. 3506(c)(2)(A)) requires Federal

agencies to provide a 60-day notice in

the Federal Register concerning each

proposed collection of information

before submitting the collection to OMB

for approval. FDA is publishing notice

of the proposed collection of

information listed below.

With respect to the following

collection of information, FDA invites

comments on: (1) Whether the proposed

collection of information is necessary

for the proper performance of FDA’s

functions, including whether the

information will have practical utility;

(2) the accuracy of FDA’s estimate of the

burden of the proposed collection of

information, including the validity of

the methodology and assumptions used;

(3) ways to enhance the quality, utility,

and clarity of the information to be

collected; and (4) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques,

when appropriate, and other forms of

information technology.

Medicated Feed Mill License

Application, Form FDA 3448 (OMB

Control Number 0910–0337)

The Animal Drug Availability Act (the

ADAA) of 1996 (Pub. L. 104–250),

which amended section 512(a) and (m)

of the Federal Food, Drug, and Cosmetic

Act (the act) (21 U.S.C. 360b(a) and (m)),

mandates that FDA replace the system

for the approval of specific medicated

feeds with a general licensing system.

The ADAA reduced the paperwork

necessary to gain approval to

manufacture medicated feeds. Before

passage of the ADAA, medicated feed

manufacturers were required to obtain

approved Medicated Feed Applications

(MFA’s) in order to manufacture certain

types of medicated feeds. A separate

approved MFA was required for each

and every applicable medicated feed.

Now, under section 512(a) and (m) of

the act as amended by the ADAA, each

feed manufacturing facility need submit

only one feed mill license application to

FDA for the manufacture of medicated

feeds. In order to be licensed in

accordance with the criteria of section

512(m)(1), a feed manufacturer must,

among other things, provide a full

statement of the business name, address,

and registration number of the feed

manufacturing facility and the name

and signature of the responsible

individual for that facility. To

implement these requirements, FDA’s

medicated feed mill license application